FDA Inspection
Enemeez, LLC dba Summit PharmaceuticalsFDA Inspection 1302518 - Enemeez, LLC dba Summit Pharmaceuticals - February 12, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Enemeez, LLC dba Summit Pharmaceuticals, with an inspection on February 12, 2026, issued by the Denver District Office, covering human drugs.
- Inspection Date
- February 12, 2026
- Product Type
- Human Drugs
- Office
- Denver District Office
Open in Dashboard
ID · 12a25bf5-77ce-4384-a93c-ff5f6e98e524
Violation Codes5
21 CFR 211.110(a)21 CFR 211.165(a)21 CFR 211.19221 CFR 211.22(d)21 CFR 211.84(d)(2)
Full citation text and observation details available on the Dashboard.